{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9016923", "DateCompleted": {"Year": "1997", "Month": "05", "Day": "29"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "318", "Issue": "2-3", "PubDate": {"Year": "1996", "Month": "Dec", "Day": "30"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models.", "Pagination": {"StartPage": "333", "EndPage": "340", "MedlinePgn": "333-40"}, "Abstract": {"AbstractText": ["We examined the effects of an aconitine-like compound, TJN-505 (1alpha-16beta-dimethoxy-20-ethyl-14alpha-(4-methox ybenzoyloxy)-aconitan-8,13-diol hydrochloride), on canine arrhythmias provoked by digitalis, two-stage coronary ligation, adrenaline, programmed electrical stimulation, or aconitine. TJN-505 (2-2.5 mg/kg i.v.) suppressed digitalis-, two-stage coronary ligation- and adrenaline-induced ventricular arrhythmias. The antiarrhythmic plasma concentrations (IC50) of TJN-505 for these arrhythmia models were 1.26, 0.94 and 1.31 microg/ml, respectively. TJN-505 (2 mg/kg i.v. followed by the infusion of 0.1 mg/kg per min) prolonged PR, QRS, QTc and JTc intervals and the ventricular effective refractory period and reduced the incidence of programmed electrical stimulation-induced arrhythmias in dogs with 7-day-old myocardial infarction (P < 0.05). TJN-505 (2 mg/kg i.v.) also suppressed the aconitine-induced atrial arrhythmias. In conclusion, TJN-505 suppressed various canine ventricular and atrial arrhythmias and seems to act as a blocker of multiple channels."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Yamanashi Medical University, Tamaho-cho, Nakakoma-gun, Japan."}], "LastName": "Arita", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Xue", "ForeName": "Y X", "Initials": "YX"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Aye", "ForeName": "N N", "Initials": "NN"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Fukuyama", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wakui", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Niitsu", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Maruno", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Siying", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hashimoto", "ForeName": "K", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Arrhythmia Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Calcium Channels"}, {"RegistryNumber": "0", "NameOfSubstance": "Potassium Channels"}, {"RegistryNumber": "0", "NameOfSubstance": "Sodium Channels"}, {"RegistryNumber": "131653-96-8", "NameOfSubstance": "TJN 505"}, {"RegistryNumber": "X8YN71D5WC", "NameOfSubstance": "Aconitine"}, {"RegistryNumber": "YKH834O4BH", "NameOfSubstance": "Epinephrine"}], "MeshHeadingList": [{"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Aconitine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Arrhythmia Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Arrhythmias, Cardiac"}, {"QualifierName": ["drug effects"], "DescriptorName": "Calcium Channels"}, {"QualifierName": [], "DescriptorName": "Digitalis"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Electrocardiography"}, {"QualifierName": [], "DescriptorName": "Epinephrine"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Potassium Channels"}, {"QualifierName": ["drug effects"], "DescriptorName": "Sodium Channels"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1996", "Month": "12", "Day": "30"}, {"Year": "1996", "Month": "12", "Day": "30", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "12", "Day": "30", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9016923", "10.1016/s0014-2999(96)00793-5", "S0014-2999(96)00793-5"]}}]}